Vectura Group ROE 2024

Vectura Group Aktienanalyse

What does Vectura Group do?

The Vectura Group PLC is a British company specializing in the development of inhalable medications. The company was founded in 1997 and is headquartered in Chippenham, England. History: Initially, Vectura focused on the development of products for the treatment of asthma and chronic obstructive pulmonary disease (COPD). In 2014, the company acquired competitor Skyepharma, expanding its product range to include a wider spectrum of inhalable medications and active ingredients. Business Model: Vectura's business model is based on collaborating with its partners to develop inhalable therapies and active ingredients. The company itself acts as a service provider, offering support to the pharmaceutical industry in the development of new solutions. Vectura has a wide range of technologies and expertise to offer its customers tailored solutions. Divisions: Vectura is divided into four different business units. "Inhaled Therapies" offers solutions for inhaling medications, including inhalers equipped with special propellants to deliver the active ingredients directly to the lungs. The "Royalty-Driven Products" division includes products for which Vectura holds licenses and benefits from the sales of these products. In the "Device Services" division, the company offers development and design services for inhalable therapies. Finally, Vectura also has a research department referred to as "New Product Opportunities," where the company works on the development of new technologies and therapies. Products: Vectura's key products include treatments for asthma and COPD, such as the inhaler Flutiform and the medication Seebri. The company also offers inhalable therapies for other diseases, such as cystic fibrosis and pulmonary hypertension. In addition to medical applications, Vectura also develops more sustainable inhalers and devices that do not rely on chlorofluorocarbons (CFCs) or other environmentally harmful propellants. Conclusion: Vectura has established itself as one of the leading companies in the field of inhalable medications. The company offers tailored solutions for its customers and invests in the development of new technologies to enhance inhalation therapy. Vectura has expanded its portfolio in recent years through the acquisition of Skyepharma and aims to further expand its market position. Vectura Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Vectura Group's Return on Equity (ROE)

Vectura Group's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Vectura Group's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Vectura Group's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Vectura Group’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Vectura Group stock

What is the ROE (Return on Equity) of Vectura Group this year?

The ROE of Vectura Group this year is 0 undefined.

How has the Return on Equity (ROE) of Vectura Group developed compared to the previous year?

The ROE of Vectura Group has increased by 0% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Vectura Group?

A high ROE indicates that Vectura Group generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Vectura Group?

A low ROE can indicate that Vectura Group is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Vectura Group affect the company?

A change in ROE (Return on Equity) of Vectura Group can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Vectura Group?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Vectura Group?

Some factors that can influence Vectura Group's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Vectura Group pay?

Over the past 12 months, Vectura Group paid a dividend of 0.06 GBP . This corresponds to a dividend yield of about 3.64 %. For the coming 12 months, Vectura Group is expected to pay a dividend of 0 GBP.

What is the dividend yield of Vectura Group?

The current dividend yield of Vectura Group is 3.64 %.

When does Vectura Group pay dividends?

Vectura Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Vectura Group?

Vectura Group paid dividends every year for the past 0 years.

What is the dividend of Vectura Group?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Vectura Group located?

Vectura Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Vectura Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vectura Group from 6/11/2021 amounting to 0.19 GBP, you needed to have the stock in your portfolio before the ex-date on 6/1/2021.

When did Vectura Group pay the last dividend?

The last dividend was paid out on 6/11/2021.

What was the dividend of Vectura Group in the year 2023?

In the year 2023, Vectura Group distributed 0 GBP as dividends.

In which currency does Vectura Group pay out the dividend?

The dividends of Vectura Group are distributed in GBP.